STAT+: Pharmalittle: Biden abandons effort to lower drug prices; cheap antidepressant holds promise in fighting Covid
Top of the morning, and a fine one it is. Clear blue skies and crisp breezes are enveloping the Pharmalot campus this morning, where the official mascot awaits a doggie playdate and we have just accepted an old-fashioned delivery of milk bottles. This, of course, makes it easier to brew a few cups of stimulation. Our choice today is candy cane (yes, this exists). As always, feel free to join us. Meanwhile, here are a few items of interest to help you on your own journey. We hope your day is productive and meaningful. And do keep in touch. …
The White House is abandoning every single policy idea aimed at lowering prescription drug prices in President Biden’s domestic spending package, STAT reports. Biden is effectively admitting he cannot overcome deeply entrenched pharmaceutical industry opposition to any change to the status quo, even with broad political support for the effort, and both chambers of Congress in Democratic control. The announcement came as part of an effort to assemble a framework for a major domestic spending package the entire Democratic caucus in Congress could support.
Continue to STAT+ to read the full story…
